Inari Medical, Inc. (NARI)


-0.48 (-0.81%)
Symbol NARI
Price $58.97
Beta 1.118
Volume Avg. 0.83M
Market Cap 3.371B
Shares () -
52 Week Range 52.59-86.94
1y Target Est -
DCF Unlevered NARI DCF ->
DCF Levered NARI LDCF ->
ROE -7.03% Neutral
ROA -5.81% Neutral
Operating Margin -
Debt / Equity 20.90% Neutral
P/E -115.63 Strong Sell
P/B 7.58 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest NARI news

Mr. Andrew J. Hykes
Medical Devices
NASDAQ Global Select

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.